Astria Therapeutics, Inc. (ATXS) Tops Q3 EPS by 16c; Reports Cash and Cash Equivalents of $131.8M
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Join SI Premium – FREE
Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of ($0.61), $0.16 better than the analyst estimate of ($0.77).
For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Hesai Group (HSAI) Tops Q1 EPS by 8c
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
